866-997-4948(US-Canada Toll Free)

Global Nuclear Medicine Market: Analysis By Product Type (Diagnostic, Therapeutic), By Diagnostic Nuclear Medicine Type, By Therapeutic Nuclear Medicine Type, By Indication, By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) -- By Diagnostic Type (SPECT, PET), By Therapeutic Type (Alpha Emitters, Beta Emitters, Brachytherapy), By Indication (Cardiovascular Disorders, Oncological Disorders, Neurological Disorders, Others)

Published By :

Azoth Analytics

Published Date : Jan 2019

Category :

Pharmaceutical

No. of Pages : 244 Pages

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Nuclear Medicine Market. The report analyzes the Nuclear Medicine Market By Product (Therapeutic, Diagnostic), By Diagnostics (SPECT, PET), By Therapeutics (Alpha Emitters, Beta Emitters, Brachytherapy) and By Indication (Cardiovascular Disorders, Oncological Disorders, Neurological Disorders, Others). The Nuclear Medicine Market has been analyzed By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S., Canada, France, Germany, India, China, Japan and Brazil) for the historical period of 2013-2017 and the forecast period of 2018-2023. 

According to Azoth Analytics research report “Global Nuclear Medicine Market: Analysis By Product Type (Diagnostic, Therapeutic), By Diagnostic Nuclear Medicine Type, By Therapeutic Nuclear Medicine Type, By Indication, By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, France, Germany, India, China, Japan, Brazil)”, global market is projected to display a robust growth represented by a CAGR of 10.07% during 2018 – 2023.

The indication segment of Oncological disorders has been witnessing growth at a noteworthy rate over the past few years backed by increased prevalence of cancer, presence of technical advance PET and SPECT equipment to perform treatment, rising number of nuclear centers Amongst the regions, North America accounts for the largest regional share in the global nuclear medicine market in 2018. Key factors driving the robust growth rate of North America region include well developed healthcare infrastructure, favorable regulatory reforms, rising prevalence of chronic ailment such as cardiovascular disorders, neurological disorders etc.  in the region.

The report titled “Global Nuclear Medicine Market: Analysis By Product Type (Diagnostic, Therapeutic), By Diagnostic Nuclear Medicine Type, By Therapeutic Nuclear Medicine Type, By Indication, By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, France, Germany, India, China, Japan, Brazil)” has covered and analyzed the potential of Global Nuclear Medicine and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global nuclear medicine devices market. Additionally, the report also highlights market entry strategies for various companies across the globe. 

Scope of the Report

Global Nuclear Medicine Market (Actual Period: 2013-2017, Forecast Period: 2018-2023
• Global Nuclear Medicine Market – Size, Growth, Forecast
• By Indication (Cardiovascular Disorders, Oncological Disorders, Neurological Disorders, Others)
• By Product Type (Diagnostic, Therapeutic)
• By Diagnostic Type (SPECT, PET)
• By Therapeutic Type (Alpha Emitters, Beta emitters, Brachytherapy)

Regional Markets – North America, Europe, APAC and Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• Nuclear Medicine Market – Size and Growth
• By Indication (Cardiovascular Disorders, Oncological Disorders, Neurological Disorders, Others) 
• By Product Type (Diagnostic, Therapeutic)
• By Diagnostic Type (SPECT, PET)
• By Therapeutic Type (Alpha Emitters, Beta emitters, Brachytherapy)

Country Analysis - U.S., Canada, Germany, United Kingdom, India, Japan China, Brazil)
• Nuclear Medicine Market – Size and Growth
• By Indication (Cardiovascular Disorders, Oncological Disorders, Neurological Disorders, Others)

Other Report Highlights
• Market Dynamics – Drivers and Restraints
• Market Trends
• Porter Five Force Analysis
• Policy and Regulatory Landscape
• Competitive Landscape
• Company Analysis – Bracco Imaging, Lantheus Holding, Curium, Jubilant Lifesciences, 3B Pharmaceutical Cardinal Health Advanced Accelerator Application, Eckert & Ziegler

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Nuclear Medicine Market Overview

5. Global Nuclear Medicine : Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)

6. Global Nuclear Medicine Market: By Indication
6.1 Global  Nuclear Medicine Market-By Product Type: Breakdown(%)
6.1.1 Global Nuclear Medicine Market  Size and Share, By Product Type, 2017
6.1.2 Global Nuclear Medicine Market  Size and Share, By Product Type, 2023
6.2 Global Diagnostic Nuclear Medicine Market Overview
6.2.1 By Value (2013-2023)
6.3 Global Therapeutic  Nuclear Medicine Market Overview
6.3.1 By Value (2013-2023)

7. Global Nuclear Medicine Market: By Therapeutic Type 
7.1 Global Nuclear Medicine Market: By Therapeutic Type : Breakdown(%)
7.1.1 Global Nuclear Medicine Market Size and Share, Market-By Therapeutic Type , 2017
7.1.2 Global Nuclear Medicine Market Size and Share, Market-By Therapeutic Type ,2023
7.2 Global  Beta Emitters Nuclear Medicine Market Overview
7.2.1 By Value (2013-2023)
7.3 Global Alpha Emitters Nuclear Medicine Market Overview
7.3.1 By Value (2013-2023)
7.4 Global Brachytherapy Nuclear Medicine Market Overview
7.4.1 By Value (2013-2023)

8. Global Nuclear Medicine Market :By Diagnostic  Type
8.1 Global Nuclear Medicine Market :By Diagnostic  Type: Breakdown(%)
8.1.1 Global Nuclear Medicine Market :By Diagnostic  Type, 2017
8.1.2 Global Nuclear Medicine Market :By Diagnostic  Type, 2023
8.2 Global SPECT Nuclear Medicine Market Overview
8.2.1 By Value (2013-2023)
8.3 Global PET Nuclear Medicine Market Overview
8.3.1 By Value (2013-2023)

9. Global Nuclear Medicine Market:By Indication
9.1 Global Nuclear Medicine Market :By Indication: Breakdown(%)
9.1.1 Global  Nuclear Medicine Market :Indication, 2017
9.1.2 Global  Nuclear Medicine Market :Indication, 2023
9.2 Global Nuclear Medicine For Oncological Disorders Market
9.2.1 By Value (2013-2023)
9.3 Global Nuclear Medicine For Cardiovascular Disorders Market
9.3.1 By Value (2013-2023)
9.4  Global Nuclear Medicine For Neurological Disorders Market
9.4.1 By Value (2013-2023)
9.5  Global Nuclear Medicine For Other Disorders Market
9.5.1 By Value (2013-2023)

10. Global Nuclear Medicine Market: Regional Analysis  
10.1 Global Nuclear Medicine Market, By Region: Breakdown (%) 
10.1.1 Global  Nuclear Medicine Market Size, By Region, 2017 (%) 
10.1.2 Global  Nuclear Medicine Market Size, By Region, 2023 (%)  
                                                   
10.2 North America Nuclear Medicine Market: An Analysis 
10.2.1 By Value (2013-2017)
10.2.2 By Value (2018-2023)

10.3 North America  Nuclear Medicine Market: Segment Analysis
10.3.1 North America  Nuclear Medicine Market: By Product Type , By Value(2013-2023)
10.3.2 North America  Nuclear Medicine Market: By Diagnostic  Type , By value (2013-2023)
10.3.3 North America  Nuclear Medicine Market: By Therapeutic  Type , By value (2013-2023)
10.3.4 North America  Nuclear Medicine Market: By Indication, By Value (2013-2023)

10.4 North America Nuclear Medicine Market: Country Analysis (U.S. and Canada)
10.4.1 U.S. Nuclear Medicine Market, By Value (2013-2023)
10.4.1.1 U.S. Nuclear Medicine Market, By Indication, By Value (2013-2023)
10.4.2 Canada Nuclear Medicine Market, By Value (2013-2023)
10.4.2.1 Canada Nuclear Medicine Market, By Indication, By Value (2013-2023)

10.5 Europe Nuclear Medicine Market: An Analysis
10.5.1 By Value (2013-2017)
10.5.2 By Value (2018-2023)

10.6 Europe Nuclear Medicine Market: Segment Analysis
10.6.1 Europe Nuclear Medicine Market: By Product Type , By Value(2013-2023)
10.6.2 Europe America  Nuclear Medicine Market: By Diagnostic  Type , By value (2013-2023)
10.6.3 Europe Nuclear Medicine Market: By Therapeutic  Type , By value (2013-2023)
10.6.4 Europe Nuclear Medicine Market: By Indication, By Value (2013-2023)

10.7 Europe Nuclear Medicine Market: Country Analysis (Germany, France., Rest of Europe)
10.7.1 Germany Nuclear Medicine Market, By Value (2013-2023)
10.7.1.1 Germany Nuclear Medicine Market, By Indication, By Value (2013-2023)
10.7.2 France  Nuclear Medicine Market, By Value (2013-2023)
10.7.2.1 France Nuclear Medicine Market, By Indication, By Value (2013-2023)
10.7.3 Rest of Europe  Nuclear Medicine Market, By Value (2013-2023)

10.8 Asia Pacific Nuclear Medicine Market: An Analysis
10.8.1 By Value (2013-2017)
10.8.2 By Value (2018-2023)

10.9 Asia Pacific Nuclear Medicine Market: Segment Analysis
10.9.1 Asia Pacific Nuclear Medicine Market: By Product Type , By Value(2013-2023)
10.9.2 Asia Pacific America  Nuclear Medicine Market: By Diagnostic  Type , By value (2013-2023)
10.9.3 Asia Pacific Nuclear Medicine Market: By Therapeutic  Type , By value (2013-2023)
10.9.4 Asia Pacific Nuclear Medicine Market: By Indication, By Value (2013-2023)

10.10 Asia Pacific  Nuclear Medicine Market: Country Analysis (India, China Japan & Rest of Asia Pacific)
10.10.1 China Nuclear Medicine Market, By Value (2013-2023)
10.10.1.1 China  Nuclear Medicine Market, By Indication, By Value (2013-2023)
10.10.2 Japan Nuclear Medicine Market, By Value (2013-2023)
10.10.2.1 Japan Nuclear Medicine Market, By Indication, By Value (2013-2023)
10.10.3 India Nuclear Medicine Market, By Value (2013-2023)
10.10.3.1 India Nuclear Medicine Market, By Indication, By Value (2013-2023)
10.10.4 Rest of Asia Pacific  Nuclear Medicine Market, By Value (2013-2023)

10.11 Rest of World Nuclear Medicine Market: An Analysis
10.11.1 By Value (2013-2017)
10.11.2 By Value (2018-2023)

10.12 Rest of World Nuclear Medicine Market: Segment Analysis
10.12.1 Rest of World Nuclear Medicine Market: By Product Type , By Value(2013-2023)
10.12.2 Rest of World Nuclear Medicine Market: By Diagnostic  Type , By value (2013-2023)
10.12.3 Rest of World Nuclear Medicine Market: By Therapeutic  Type , By value (2013-2023)
10.12.4 Rest of World Nuclear Medicine Market: By Indication, By Value (2013-2023)

10.13 Rest of World Nuclear Medicine Market: Country Analysis (Brazil & Others)
10.13.1 Brazil Nuclear Medicine Market, By Value (2013-2023)
10.13.1 Brazil  Nuclear Medicine Market, By Indication, By Value (2013-2023)
10.13.2 Others Nuclear Medicine Market, By Value (2013-2023)

11. Market Dynamics
11.1 Drivers
11.2 Challenges

12. Market Trends

13. Porter’s Five Forces Analysis –Nuclear Medicine Market  
                                                                                              
14. SWOT Analysis –Nuclear Medicine Market 

15. Supply Chain Analysis Nuclear Medicine Market

16. Policy and Regulatory Landscape

17. Competitive Landscape

18. Company Profiles
18.1 Eckert & Ziegler
18.2 Advanced Accelerator Applications
18.3 Cardinal Health
18.4 3B Pharmaceuticals
18.5 Jubilant Life Sciences
18.6 Curium
18.7 Lantheus Holdings
18.8 Bracco Imaging

List of Table

Table A: List of Abbreviations
Table B: Recent Company Acquisitions ,Mergers & Partnership  in Nuclear Medicine Market
Table C: Pipeline of Diagnostic Nuclear Medicine
Table D: Pipeline of Diagnostic Nuclear Medicine
Table E: Pipeline of Diagnostic Nuclear Medicine
Table F: Pipeline of Diagnostic Nuclear Medicine
Table G: Radionuclide Used for Diagnosis and Treatment 
Table H: Physical Properties of Radionuclides Used in Therapeutic Nuclear Medicine Studies 
Table I: Physical Properties of Radionuclides Used in Therapeutic Nuclear Medicine Studies 

List of Chart

Figure 1: Nuclear Medicine Market Segmentation Flowchart
Figure 2: Nuclear Medicine Market Segmentation Flowchart
Figure 3: Global Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
Figure 4: Global  Nuclear Medicine Market Size, By Value, Forecast, 2018-2023(USD Million)
Figure 5: Population ages 65 and above, By Select Region, 2013-2017 (% of total)
Figure 6: Projected global population aged 60 years & above In Billions)
Figure 7: Projected global population (In Billions)
Figure 8: Global Health Expenditure Per Capita, (2012-2016, USD Trillion)
Figure 9: Global Health Expenditure Per Capita, By Select Countries,(2016, USD)
Figure 10: Global Nuclear Medicine Market  Size, By Product Type, 2017 (%)
Figure 11: Global Nuclear Medicine Market Size, By Product  Type, 2023F (%)
Figure 12: Global Diagnostic Nuclear Medicine Market Size, By Value,2013-2017(USD Million)
Figure 13: Global Diagnostic Nuclear Medicine Market Size, By Value,2018E-2023F (USD Million)
Figure 14: Global Therapeutic Nuclear Medicine Market Size, By Value,2013-2017(USD Million)
Figure 15: Global Therapeutic Nuclear Medicine Market Size, By Value,2018E-2023F (USD Million)
Figure 16: Global Prevalence of Different Type of Cancer (2013-2017, Thousands)
Figure 17: Global Nuclear Medicine Market Size, By Therapeutic Type, 2017 (%)
Figure 18: Global Nuclear Medicine Market Size, By Diagnostic Type, 2023F (%)
Figure 19: Global Beta Emitters Nuclear Medicine Market Size, By Value,2013-2017(USD Million)
Figure 20: Global Beta Emitters  Nuclear Medicine Market Size, By Value,2018E-2023F (USD Million)
Figure 21: Global Alpha Emitter Nuclear Medicine Market Size, By Value,2013-2017(USD Million)
Figure 22: Global Alpha Emitter Nuclear Medicine Market Size, By Value,2018E-2023F (USD Million)
Figure 23: Global Brachytherapy Nuclear Medicine Market Size, By Value,2013-2017(USD Million)
Figure 24: Global Brachytherapy Nuclear Medicine Market Size, By Value,2018E-2023F (USD Million)
Figure 25: Global Nuclear Medicine Market Size, By Diagnostic Type, 2017 (%)
Figure 26: Global Nuclear Medicine Market Size, By Diagnostic Type, 2023F (%)
Figure 27: Global SPECT Nuclear Medicine Market Size, By Value,2013-2017(USD Million)
Figure 28: Global SPECT Nuclear Medicine Market Size, By Value,2018E-2023F (USD Million)
Figure 29: Global PET Nuclear Medicine Market Size, By Value, 2013-2017(USD Million)
Figure 30: Global PET Nuclear Medicine Market Size, By Value, 2018E-2023F (USD Million)
Figure 31: Global Nuclear Medicine Market  Size, By Indication, 2017 (%)
Figure 32: Global Nuclear Medicine Market Size, By Indication, 2023 (%)
Figure 33: Global Nuclear Medicine For Oncological Disorders  Market Size, By Value,2013-2017(USD Million)
Figure 34: Global Nuclear Medicine  For Oncological Disorders  Market Size, By Value,2018E-2023F (USD Million)
Figure 35: Prevalence of  Cancer Per 100,000 in different Countries in 2018 ( In Thousands)
Figure 36: Global Prevalence of Different Type of Cancer in year 2016 & 2017 ( In Thousands)
Figure 37: Global Nuclear Medicine For Cardiovascular Disorders Market Size, By Value, 2013-2017(USD Million)
Figure 38: Global Nuclear Medicine For Cardiovascular Disorders Market Size, By Value, 2018E-2023F (USD Million)
Figure 39: Global Nuclear Medicine For Cardiovascular Disorders Market Size, By Value, 2018E-2023F (USD Million)
Figure 40: Global Prevalence of Cardiovascular Disease (2012-2016 , Million)
Figure 41: Global Nuclear Medicine For Neurological Disorders Market Size, By Value,2013-2017(USD Million)
Figure 42: Global Nuclear Medicine For Neurological Disorders Market Size, By Value,2018E-2023F (USD Million)
Figure 43: Global Nuclear Medicine For Others Disorders Market Size, By Value,2013-2017(USD Million)
Figure 44: Global Nuclear Medicine For Others Disorders Market Size, By Value,2013-2017(USD Million)
Figure 45: Global Nuclear Medicine Market  Size, By Region, 2017 (%)
Figure 46: Global Nuclear Medicine Market  Size, By Region, 2023F (%)
Figure 47: North America  Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
Figure 48: North America Population above 65 year in Million (2015, 2030F, 2050F) 
Figure 49: North America Nuclear Medicine Market Size, By Value, Forecast, 2018-2023(USD Million )
Figure 50: North America Nuclear Medicine Market : By Product , By Value, 2013-2023 (USD Million)
Figure 51: North America Nuclear Medicine Market : By Diagnostic Type , By Value, 2013-2023 (USD Million)
Figure 52: North America Nuclear Medicine Market : By Therapeutic  Type , By Value, 2013-2023 (USD Million)
Figure 53: North America Nuclear Medicine Market : By Therapeutic  Type , By Value, 2013-2023 (USD Million)
Figure 54: North America Nuclear Medicine Market : By Therapeutic  Type , By Value, 2013-2023 (USD Million)
Figure 55: Total Number of People With Cardiovascular Disorders in North America, By Type,2017  (In thousands)
Figure 56: Prevalence of Different Type of Cancer in North America in year 2016 & 2017 ( In Hundreds)
Figure 57: North America   Nuclear Medicine Market, Country Share, 2017 (% of Total)
Figure 58: North America Nuclear Medicine , Country Share, 2023F (% of Total)
Figure 59: United States Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
Figure 60: United States Nuclear Medicine Market Size, By Value, 2018E-2023F (USD Million)
Figure 61: U.S. Per Capita Health Expenditure, 2012-2016 ( USD)
Figure 62: United States Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)
Figure 63: New Estimated Cases of Cancer in United States, By  Type 2018 
Figure 64: New Estimated Cases of Cancer in United States (2014-2018)
Figure 65: Estimated Cases of Cardiovascular Disorders in United States (2013-2017)(In Thousands)
Figure 66: United States Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Figure 67: Total Number of People With Cardiovascular Disorders in United States, By Type,2017  (In thousands)
Figure 68: Total Number of People With Cardiovascular Disorders in United States, By Type,2017  (In thousands)
Figure 69: Canada Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million)
Figure 70: Canada Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)
Figure 71: Canada Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Figure 72: Total Number of People With Cardiovascular Disorders in Canada, By Type,2017  (In thousands)
Figure 73: Prevalence of Different Type of Cancer in Canada in year 2016 & 2017 ( In Hundreds)
Figure 74: Cancer Fact Sheet of Canada, 2017 
Figure 75: Europe Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
Figure 76: Europe Nuclear Medicine Market Size, By Value, Forecast, 2018-2023(USD Million )
Figure 77: Number of Magnetic Resonance Imaging (MRI) Scans By Using Imaging Equipment Number, 2016, Per 100,000 Inhabitants
Figure 78: Europe Nuclear Medicine Market : By Product , By Value, 2013-2023 (USD Million)
Figure 79: Europe Nuclear Medicine Market : By Diagnostic Type , By Value, 2013-2023 (USD Million)
Figure 80: Europe Nuclear Medicine Market : By Therapeutic  Type , By Value, 2013-2023 (USD Million)
Figure 81: Europe Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)
Figure 82: Prevalence of Different Type of Cancer in Western Europe in year 2016 & 2017 ( In Hundreds)
Figure 83: Western Europe Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Figure 84: Total Number of People With Cardiovascular Disorders in Western  Europe, By Type,2017  (In thousands)
Figure 85: Europe  Nuclear Medicine Market, Country Share, 2017 (% of Total)
Figure 86: Europe  Nuclear Medicine Market, Country Share, 2023 (% of Total)
Figure 87: Germany Nuclear Medicine Market    Size, By Value, 2013-2017 (USD Million)
Figure 88: Germany Nuclear Medicine Market Size, By Value, 2018E-2023F (USD Million)
Figure 89: Germany  Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)
Figure 90: Germany Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Figure 91: Total Number of People With Cardiovascular Disorders in Germany, By Type,2017  (In thousands)
Figure 92: Total Number of People With Cardiovascular Disorders in Germany, By Type,2017  (In thousands)
Figure 93: France Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
Figure 94: France Nuclear Medicine Market Size, By Value, 2018E-2023F (USD Million)
Figure 95: France  Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)
Figure 96: France Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Figure 97: Total Number of People With Cardiovascular Disorders in France, By Type,2017  (In thousands)
Figure 98: Prevalence of Different Type of Cancer in France in year 2016 & 2017 ( In Hundreds)
Figure 99: Rest of Europe Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
Figure 100: Rest of Europe Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million)
Figure 101: Rest of Europe Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million)
Figure 102: Asia Pacific Nuclear Medicine Market Size, By Value, Forecast, 2018-2023(USD Million )
Figure 103: Asia Pacific Nuclear Medicine Market : By Product , By Value, 2013-2023 (USD Million)
Figure 104: Rest of World  Nuclear Medicine Market : By Diagnostic Type , By Value, 2013-2023 (USD Million)
Figure 105: Asia Pacific  Nuclear Medicine Market : By Therapeutic  Type , By Value, 2013-2023 (USD Million)
Figure 106: Asia Pacific Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)
Figure 107: Asia Pacific Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Figure 108: Total Number of People With Cardiovascular Disorders in Asia Pacific, By Type,2017  
Figure 109: Asia Pacific Nuclear Medicine Market, Country Share, 2017 (% of Total)
Figure 110: Asia Pacific Nuclear Medicine, Country Share, 2023 (% of Total)
Figure 111: China  Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
Figure 112: China Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million)
Figure 113: China Healthcare Expenditure (2012-2016, USD Billion)
Figure 114: China Population 65 Years & Above (% of Total), 2012-2016 
Figure 115: China Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)
Figure 116: China Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Figure 117: Total Number of People With Cardiovascular Disorders in China, By Type,2017  (In thousands)
Figure 118: Prevalence of Different Type of Cancer in China in year 2016 & 2017 ( In Hundreds)
Figure 119: Japan Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
Figure 120: Japan Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million)
Figure 121: Japan Per Capita Health Expenditure (2012-2016,USD)
Figure 122: Japan Population 65  Years & Above (% of Total), 2012-2016 
Figure 123: Japan Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)
Figure 124: Japan Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Figure 125: Total Number of People With Cardiovascular Disorders in Japan, By Type,2017  (In thousands)
Figure 126: Prevalence of Different Type of Cancer in Japan in year 2016 & 2017 ( In Hundreds)
Figure 127: India Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million )
Figure 128: India Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million)
Figure 129: India Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)
Figure 130: Rest of Asia Pacific Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
Figure 131: Rest of Asia Pacific Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million)
Figure 132: Rest of World Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
Figure 133: Rest of World Nuclear Medicine Market Size, By Value, Forecast, 2018-2023(USD Million )
Figure 134: Rest of World Nuclear Medicine Market : By Product , By Value, 2013-2023 (USD Million)
Figure 135: Rest of World Nuclear Medicine Market : By Diagnostic Type , By Value, 2013-2023 (USD Million)
Figure 136: Rest of World Nuclear Medicine Market : By Diagnostic Type , By Value, 2013-2023 (USD Million)
Figure 137: Rest of World Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)
Figure 138: North Africa and Middle East Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Figure 139: Total Number of People With Cardiovascular Disorders in North Africa and Middle East , By Type,2017 (In thousands)
Figure 140: Prevalence of Different Type of Cancer in Middle East and North Africa  in year 2016 & 2017 ( In Hundreds)
Figure 141: Rest of World Nuclear Medicine Market, Country Share, 2017 (% of Total)
Figure 142: Rest of World Nuclear Medicine , Country Share, 2023 (% of Total)
Figure 143: Brazil Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
Figure 144: Brazil Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million
Figure 145: Brazil Nuclear Medicine Market : By Indication, By Value, 2013-2023 (USD Million)
Figure 146: Brazil Prevalence of Different Type of Neurological Disorders (2016-17, In Thousands)
Figure 147: Total Number of People With Cardiovascular Disorders in Brazil, By Type,2017  (In thousands)
Figure 148: Prevalence of Different Type of Cancer in Brazil  in year 2016 & 2017 ( In Hundreds)
Figure 149: Others Nuclear Medicine Market Size, By Value, 2013-2017 (USD Million)
Figure 150: Others Nuclear Medicine Market Size By Value, 2018E-2023F (USD Million)
Figure 151: Eckert &Ziegler Sales, 2013-2017 (USD Million)
Figure 152: Eckert &Ziegler Sales, By Business Group, 2017 (%)
Figure 153: Advanced Accelerator Applications Sales, 2014-2016 (USD Million)
Figure 154: Advanced Accelerator Applications Sales, By Business Group, 2017 (%)
Figure 155: Advanced Accelerator Applications Sales, By Region, 2017 (%)
Figure 156: Cardinal Health Sales, 2013-2017 (USD Billion)
Figure 157: Cardinal Health Sales, By Business Group, 2017 (%)
Figure 158: Cardinal Health Sales, By Region, 2017 (%)
Figure 159: Jubilant Life Sciences Sales, 2015FY-2018FY (USD Million)
Figure 160: Jubilant Life Sciences Sales, By Business Group, 2017 (%)
Figure 161: Jubilant Life Sciences Sales, By Region, 2017 (%)
Figure 162: Lantheus  Holdings Revenue ,2016-2017 (USD Million)
Figure 163: Lantheus  Holdings Revenue, By Product, 2017 (%)
Figure 164: Lantheus  Holdings Revenue , By Region, 2017 (%)
Figure 165: Bracco Imaging Revenue , By Region, 2017 (%)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *